期刊文献+

原发性肝癌组织中OPN、GP73的表达变化及意义 被引量:5

暂未订购
导出
摘要 目的观察原发性肝癌组织中骨桥蛋白(OPN)和高尔基体糖蛋白-73(GP73)的表达变化并探讨其意义。方法采用免疫组化SP法检测45例肝癌组织(肝癌组)和15例正常肝组织(对照组)中的OPN与GP73,观察不同临床病理特征肝癌患者肝脏组织中两者的表达变化。结果肝癌组OPN表达阳性率为71.1%(32/45),GP73表达阳性率为91.1%(41/45),高于对照组的15%(3/20)、0%(0/20),P均<0.05。OPN和GP73的表达在不同淋巴结转移情况、Edmondson分级和TNM分期者中差异有统计学意义(P均<0.05),且两者在肝癌组织中的表达呈正相关关系(r=0.569,P<0.01)。结论肝癌组织中OPN和GP73的表达高于正常肝组织,二者可能与肝癌的发生发展有关。
作者 高万军 祁楠
出处 《山东医药》 CAS 2014年第2期60-61,共2页 Shandong Medical Journal
  • 相关文献

参考文献14

  • 1Gao J,Xie L,Yang WS. Risk factors of hepatocellular carcinoma-current status and perspectives[J].Asian Pac J Cancer Prey,2012,(3):743-752.
  • 2Deng B,Zhang XF,Zhu XC. Correlation and prognostic value of osteopontin and Bcl-2 in hepatocellular carcinoma patients after curative resection[J].{H}Oncology Reports,2013,(6):2795-2803.
  • 3Gotoh M,Sakamoto M,Kanetaka K. Overexpression of osteopontin in hepatocellular carcinoma[J].{H}Pathology International,2002,(1):19-24.
  • 4Mao Y,Yang H,Xu H. Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma[J].{H}GUT,2010,(12):1687-1693.
  • 5Bellahcène A,Castronovo V,Ogbureke KU. Small integrinbinding ligand N-linked glycoproteins (SIBLINGs):multifunctional proteins in cancer[J].{H}Nature Reviews Cancer,2008,(3):212-226.
  • 6Rangaswami H,Bulbule A,Kundu GC. Osteopontin:role in cell signaling and cancer progression[J].{H}Trends in Cell Biology,2006,(2):79-87.
  • 7Jain S,Chakraborty G,Bulbule A. Osteopontin:an emerging therapeutic target for anticancer therapy[J].{H}EXPERT OPINION ON THERAPEUTIC TARGETS,2007,(1):81-90.
  • 8Ahmed M,Behera R,Chakraborty G. Osteopontin:a potentially important therapeutic target in cancer[J].{H}EXPERT OPINION ON THERAPEUTIC TARGETS,2011,(9):1113-1126.
  • 9Pan HW,Ou YH,Peng SY. Overexpression of osteopontin is associated with intrahepatic metastasis,early recurrence,and poorer prognosis of surgically resected hepatocellular carcinoma[J].{H}CANCER,2003,(1):119-127.
  • 10Kumar S,Sharma P,Kumar D. Functional characterization of stromal osteopontin in melanoma progression and metastasis[J].PLoS One,2013,(7):e69116.

同被引文献70

  • 1陈晓香,孙萍,姚晓宾.鳞状细胞癌抗原检测在原发性肝癌诊断中的意义[J].中国实用医刊,2010,37(14):69-70. 被引量:2
  • 2Kikuchi L, Paranagua-Vezozzo D, Chagas A, et al, Nodules less than 20 mm and vascular invasion are predictors of survival in small hepatoeellular carcinoma[ J ]. J Clin Gastroenterol, 2009,43 (2) : 191-195.
  • 3Gao J, Xie L, Yang WS, et al. Risk factors of hepatocellular car-cinoma-current status and perspectives [ J ]. Asian Pae J Cancer Prey, 2012,13 ( 3 ) :743-752.
  • 4Kim KA, Lee JS, Jung ES, et al. Usefulness of serum alpha-feto- protein (AFP) as a marker for hepatocellular carcinoma (I-ICC) in hepatitis C virus relatede cirrhosis: analysis of the factors influen- cing AFP elevation without HCC development [ J ]. Korean J Gas- troenterol, 2006,48 (5) :321-326.
  • 5Kladney KD, Bulla GA, Guo L, et al. GP73, a novel Golgilocal- ized protein upregulated by viral infegtion [ J ]. Gene, 2000,249 ( 1-2 ) :53-65.
  • 6Wright LM, Huster D, Lutsenko S, et al. Hepatocyte GP73 ex- pression in Wilson disease[ J] Hepatol, 2009,51 ( 3 ) :557-564.
  • 7Pontisso P, Calabrese F, Benvegnu L, et al. Overexpressian of squamous cell carcinoma antigen variants in hepatocellular carcino- ma[J]. Sr J Cancer, 2004,90(4) :833-837.
  • 8Giannelli G, Marinosci F, Trerotoli P, et al. SCCA antigen com- bined with alpha-fetoprotein as serologic markers of HCC[J]. IntJ Cancer, 2005, 117(3) :506-509.
  • 9Oldberg A, Franzen A, Heinegard D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly Asp cell-binding sequence. Proc Natl Acad Sci U S A, 1986, 83:8819-8823.
  • 10Anborgh PH, Mutrie JC, Tuck AB, et al. Role of the metastasis- promoting protein osteopontin in the tumour mieroenvironment. J Cell Mol Med, 2010, 14: 2037-2044.

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部